Genetic Variants Associated with Drug Resistance of Cytomegalovirus in Hematopoietic Cell Transplantation Recipients
Viruses · 2023
DOI: 10.3390/v15061286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Seungwan Chae und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Fund of Seoul St. Mary’s Hospital, The Catholic University of Korea.
Abstract (Originalsprache)
Cytomegalovirus (CMV) infection is a serious complication in hematopoietic cell transplantation (HCT) recipients. Drug-resistant strains make it more challenging to treat CMV infection. This study aimed to identify variants associated with CMV drug resistance in HCT recipients and assess their clinical significance. A total of 123 patients with refractory CMV DNAemia out of 2271 HCT patients at the Catholic Hematology Hospital between April 2016 and November 2021 were analyzed, which accounted for 8.6% of the 1428 patients who received pre-emptive therapy. Real-time PCR was used to monitor CMV infection. Direct sequencing was performed to identify drug-resistant variants in UL97 and UL54. Resistance variants were found in 10 (8.1%) patients, and variants of uncertain significance (VUS) were found in 48 (39.0%) patients. Patients with resistance variants had a significantly higher peak CMV viral load than those without (p = 0.015). Patients with any variants had a higher risk of severe graft-versus-host disease and lower one-year survival rates than those without (p = 0.003 and p = 0.044, respectively). Interestingly, the presence of variants reduced the rate of CMV clearance, particularly in patients who did not modify their initial antiviral regimen. However, it had no apparent impact on individuals whose antiviral regimens were changed due to refractoriness. This study highlights the importance of identifying genetic variants associated with CMV drug resistance in HCT recipients for providing appropriate antiviral treatment and predicting patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Catholic Genetic Laboratory Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Vaccine Bio Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Catholic Hematology Hospital, Seoul St. Mary's Hospital, Seoul 06591, Republic of Korea.
ORCID-Profile: Seungwan Chae, Hoon Seok Kim, Dukhee Nho, Raeseok Lee, Dong-Gun Lee, Myungshin Kim
Förderung
- Research Fund of Seoul St. Mary’s Hospital, The Catholic University of Korea
Zitieren
APA
Chae, S., Kim, H. S., Cho, S. Y., Nho, D., Lee, R., Lee, D. G., Kim, M., & Kim, Y. (2023). Genetic Variants Associated with Drug Resistance of Cytomegalovirus in Hematopoietic Cell Transplantation Recipients. Viruses. https://doi.org/10.3390/v15061286
Vancouver
Chae S, Kim HS, Cho SY, Nho D, Lee R, Lee DG, et al. Genetic Variants Associated with Drug Resistance of Cytomegalovirus in Hematopoietic Cell Transplantation Recipients. Viruses. 2023. doi:10.3390/v15061286
BibTeX
@article{Chae2023,
author = {Chae, Seungwan and Kim, Hoon Seok and Cho, Sung-Yeon and Nho, Dukhee and Lee, Raeseok and Lee, Dong-Gun and Kim, Myungshin and Kim, Yonggoo},
title = {Genetic Variants Associated with Drug Resistance of Cytomegalovirus in Hematopoietic Cell Transplantation Recipients},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15061286}
}
EUVIMED